|
2023
|
Invention
|
Transposon, gene transfer system and method of using the same.
The present invention refers to h... |
|
2022
|
Invention
|
Increase of protein expression and secretion by artificial co-expression of hdlbp/vigilin.
The i... |
|
|
Invention
|
Method for gene repair in primary human muscle stem cells (satellite cells) in vitro and genetica... |
|
2020
|
Invention
|
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the s... |
|
|
Invention
|
High affinity t cell receptor and use thereof.
The present invention is directed to a high affin... |
|
2019
|
Invention
|
Eicosanoid derivatives. The present invention provides compounds (n-3 PUFA derivatives) of formul... |
|
2018
|
Invention
|
Antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such a... |
|
2017
|
Invention
|
Use of aptamers in therapy and/or diagnosis of autoimmune diseases. The present invention is dire... |
|
|
Invention
|
High affinity t cell receptor and use thereof. The present invention is directed to a high affini... |
|
|
Invention
|
Transposon, gene transfer system and method of using the same. The present invention refers to hy... |
|
2016
|
Invention
|
Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof.
The pr... |
|
2015
|
Invention
|
Nucleic acids encoding sb10 variants. The present invention refers to hyperactive variants of a t... |
|
|
Invention
|
Tgif2-induced reprogramming of hepatic cells to pancreatic progenitor cells and medical uses ther... |
|
|
Invention
|
Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in a... |
|
|
Invention
|
Short term isotope pulse labeling method for analysing metabolic products in biological samples. ... |
|
|
Invention
|
Lrrc8 proteins and protein complexes and methods for identification of channel modulators. The in... |
|
|
Invention
|
Cyp-eicosanoid derivatives. The present invention relates to compounds according to general formu... |
|
2013
|
Invention
|
Psoralen derivatives for preventing or treating heart failure or cardiac hypertrophy.
The presen... |
|
|
Invention
|
Method for fast spin-echo mrt imaging.
The invention relates to a method for fast autocalibrated... |
|
|
Invention
|
Beta-l-n4 hydroxycytosine deoxynucleosides and their use as pharmaceutical agents in the prophyla... |
|
2012
|
Invention
|
Niclosamide for the treatment of cancer metastasis.
The invention relates to niclosamide and der... |
|
2011
|
Invention
|
Biomarkers for determination of temporal phase of acute kidney injury. The invention relates to a... |
|
|
Invention
|
Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collater... |
|
|
Invention
|
Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates. The pres... |
|
|
Invention
|
Magnetic field apparatus and method of operating a magnetic field apparatus.
A magnetic field ap... |
|
2010
|
Invention
|
Enhancers of protein degradation. The present invention relates to compounds suitable for modulat... |
|
|
Invention
|
Multiple target t cell receptor.
The present invention is directed to a functional T cell recept... |
|
|
Invention
|
Use of metastasis progressor s100a4 transcripts in body fluids of colorectal and gastric cancer p... |
|
|
Invention
|
Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof. The pre... |
|
2009
|
Invention
|
Remedy for the treatment of cardio-vascular diseases or disorders. Disclosed is the use of inhibi... |
|
2008
|
Invention
|
Therapy and use of compounds in therapy.
A method of treating, preventing or ameliorating chroni... |
|
|
Invention
|
Polypeptide variants of sleeping beauty transposase. The present invention refers to hyperactive ... |
|
|
Invention
|
Tumour vaccines for muc1-positive carcinomas.
Embodiments of the invention provide tumour vaccin... |
|
2007
|
Invention
|
Identification of agonistic autoantibodies associated with humoral kidney rejection.
The inventi... |
|
|
Invention
|
Peptides regulating the surface expression of the t cell receptor. The present invention is relat... |
|
|
Invention
|
Method for modulating, treating and/or preventing metabolic syndrome using mas-g-protein-coupled ... |
|
|
Invention
|
Use of pol iii promoters for controlled expression of therapeutic proteins. The present invention... |
|
2006
|
Invention
|
Generation of antigen specific t cells. The present invention is directed to a method of generati... |
|
2005
|
Invention
|
Beta-l-n4-hydroxycytosine deoxynucleosides and their use as pharmaceutical agents in the prophyla... |
|
|
Invention
|
Pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegener... |
|
2002
|
Invention
|
Implantable active ingredient depot. The invention relates to an implantable active ingredient de... |
|
|
Invention
|
1 receptor and their uses. 1 receptor and their use for eliminating specifically binding, cell-ph... |
